{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:04:51Z","timestamp":1793484291764,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the NSRF via the Program Management Unit for Human Resources & Institutional Development, Research and Innovation","award":["PMU-B, grant number B36G660010"],"award-info":[{"award-number":["PMU-B, grant number B36G660010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20266-5","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:56:35Z","timestamp":1760612195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dietary composition modulate gut microbiota and related biomarkers in patients with chronic kidney disease"],"prefix":"10.1038","volume":"15","author":[{"given":"Suwasin","family":"Udomkarnjananun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthaya","family":"Chuaypen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamonchanok","family":"Metta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thasinas","family":"Dissayabutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pimpayao","family":"Sodsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyawan","family":"Kittiskulnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisit","family":"Tangkijvanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"9","key":"20266_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41581-020-0297-2","volume":"16","author":"JJ Carrero","year":"2020","unstructured":"Carrero, J. J. et al. Plant-based diets to manage the risks and complications of chronic kidney disease. Nat. Rev. Nephrol. 16 (9), 525\u2013542 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"20266_CR2","doi-asserted-by":"crossref","unstructured":"Sakaguchi, Y., Kaimori, J. Y. & Isaka, Y. Plant-Dominant low protein diet: A potential alternative dietary practice for patients with chronic kidney disease. Nutrients.  15(4), 1002 (2023).","DOI":"10.3390\/nu15041002"},{"key":"20266_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev-nutr-071714-034426","volume":"37","author":"AL Kamper","year":"2017","unstructured":"Kamper, A. L. & Strandgaard, S. Long-Term effects of High-Protein diets on renal function. Annu. Rev. Nutr. 37, 347\u2013369 (2017).","journal-title":"Annu. Rev. Nutr."},{"issue":"11","key":"20266_CR4","doi-asserted-by":"publisher","first-page":"e0206134","DOI":"10.1371\/journal.pone.0206134","volume":"13","author":"B Yan","year":"2018","unstructured":"Yan, B., Su, X., Xu, B., Qiao, X. & Wang, L. Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis. PLoS One. 13 (11), e0206134 (2018).","journal-title":"PLoS One"},{"issue":"8","key":"20266_CR5","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1681\/ASN.2020010028","volume":"31","author":"GJ Ko","year":"2020","unstructured":"Ko, G. J., Rhee, C. M., Kalantar-Zadeh, K. & Joshi, S. The effects of High-Protein diets on kidney health and longevity. J. Am. Soc. Nephrol. 31 (8), 1667\u20131679 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"20266_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1681\/ASN.2020030384","volume":"32","author":"JT Kelly","year":"2021","unstructured":"Kelly, J. T. et al. Modifiable lifestyle factors for primary prevention of CKD: A systematic review and Meta-Analysis. J. Am. Soc. Nephrol. 32 (1), 239\u2013253 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"key":"20266_CR7","doi-asserted-by":"crossref","unstructured":"KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2024; 105(4s): S117-s314. (2024).","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"3","key":"20266_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.ajkd.2015.09.027","volume":"67","author":"A Ramezani","year":"2016","unstructured":"Ramezani, A. et al. Role of the gut Microbiome in uremia: A potential therapeutic target. Am. J. Kidney Dis. 67 (3), 483\u2013498 (2016).","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"20266_CR9","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12967-023-04455-2","volume":"21","author":"Z Tang","year":"2023","unstructured":"Tang, Z., Yu, S. & Pan, Y. The gut Microbiome Tango in the progression of chronic kidney disease and potential therapeutic strategies. J. Transl Med. 21 (1), 689 (2023).","journal-title":"J. Transl Med."},{"issue":"2","key":"20266_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-022-00647-z","volume":"19","author":"H Krukowski","year":"2023","unstructured":"Krukowski, H. et al. Gut Microbiome studies in CKD: opportunities, pitfalls and therapeutic potential. Nat. Rev. Nephrol. 19 (2), 87\u2013101 (2023).","journal-title":"Nat. Rev. Nephrol."},{"issue":"6S","key":"20266_CR11","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","volume":"33","author":"K Lambert","year":"2023","unstructured":"Lambert, K. et al. Targeting the gut microbiota in kidney disease: the future in renal nutrition and metabolism. J. Ren. Nutr. 33 (6S), S30\u2013S9 (2023).","journal-title":"J. Ren. Nutr."},{"issue":"8","key":"20266_CR12","doi-asserted-by":"publisher","first-page":"e2000851","DOI":"10.1002\/mnfr.202000851","volume":"65","author":"M Snelson","year":"2021","unstructured":"Snelson, M. et al. Long term high protein diet feeding alters the Microbiome and increases intestinal permeability, systemic inflammation and kidney injury in mice. Mol. Nutr. Food Res. 65 (8), e2000851 (2021).","journal-title":"Mol. Nutr. Food Res."},{"key":"20266_CR13","doi-asserted-by":"crossref","unstructured":"Evenepoel, P., Meijers, B. K., Bammens, B. R. & Verbeke, K. Uremic toxins originating from colonic microbial metabolism. Kidney Int. Suppl.  76(114), S12\u2013S19 (2009).","DOI":"10.1038\/ki.2009.402"},{"issue":"9","key":"20266_CR14","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1681\/ASN.2013101062","volume":"25","author":"R Vanholder","year":"2014","unstructured":"Vanholder, R., Schepers, E., Pletinck, A., Nagler, E. V. & Glorieux, G. The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review. J. Am. Soc. Nephrol. 25 (9), 1897\u20131907 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"20266_CR15","doi-asserted-by":"publisher","first-page":"105313","DOI":"10.1016\/j.isci.2022.105313","volume":"25","author":"A Bartlett","year":"2022","unstructured":"Bartlett, A. & Kleiner, M. Dietary protein and the intestinal microbiota: an understudied relationship. iScience 25 (11), 105313 (2022).","journal-title":"iScience"},{"issue":"9","key":"20266_CR16","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/ndt\/gfq815","volume":"26","author":"K Praditpornsilpa","year":"2011","unstructured":"Praditpornsilpa, K. et al. The need for robust validation for MDRD-based glomerular filtration rate Estimation in various CKD populations. Nephrol. Dial Transpl. 26 (9), 2780\u20132785 (2011).","journal-title":"Nephrol. Dial Transpl."},{"key":"20266_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.trsl.2021.01.009","volume":"233","author":"I Cohen","year":"2021","unstructured":"Cohen, I., Ruff, W. E. & Longbrake, E. E. Influence of Immunomodulatory drugs on the gut microbiota. Transl Res. 233, 144\u2013161 (2021).","journal-title":"Transl Res."},{"issue":"1","key":"20266_CR18","doi-asserted-by":"publisher","first-page":"e13397","DOI":"10.1111\/tid.13397","volume":"23","author":"CM Gibson","year":"2021","unstructured":"Gibson, C. M., Childs-Kean, L. M., Naziruddin, Z. & Howell, C. K. The alteration of the gut Microbiome by immunosuppressive agents used in solid organ transplantation. Transpl. Infect. Dis. 23 (1), e13397 (2021).","journal-title":"Transpl. Infect. Dis."},{"issue":"3 Suppl 1","key":"20266_CR19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","volume":"76","author":"TA Ikizler","year":"2020","unstructured":"Ikizler, T. A. et al. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am. J. Kidney Dis. 76 (3 Suppl 1), S1\u2013s107 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"20266_CR20","unstructured":"Judprasong, K. et al. August. Institute of Nutrition, Mahidol University. Thai Food Composition Database, Online version 2. 2018. (2024). https:\/\/inmu2.mahidol.ac.th\/thaifcd\/home.php"},{"issue":"6","key":"20266_CR21","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1128\/AEM.02561-06","volume":"73","author":"P Louis","year":"2007","unstructured":"Louis, P. & Flint, H. J. Development of a semiquantitative degenerate real-time pcr-based assay for Estimation of numbers of butyryl-coenzyme A (CoA) coa transferase genes in complex bacterial samples. Appl. Environ. Microbiol. 73 (6), 2009\u20132012 (2007).","journal-title":"Appl. Environ. Microbiol."},{"key":"20266_CR22","doi-asserted-by":"publisher","first-page":"717925","DOI":"10.3389\/fnut.2021.717925","volume":"8","author":"T Vanuytsel","year":"2021","unstructured":"Vanuytsel, T., Tack, J. & Farre, R. The role of intestinal permeability in Gastrointestinal disorders and current methods of evaluation. Front. Nutr. 8, 717925 (2021).","journal-title":"Front. Nutr."},{"key":"20266_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jpba.2015.02.040","volume":"109","author":"AJ Ocque","year":"2015","unstructured":"Ocque, A. J., Stubbs, J. R. & Nolin, T. D. Development and validation of a simple UHPLC-MS\/MS method for the simultaneous determination of trimethylamine N-oxide, choline, and betaine in human plasma and urine. J. Pharm. Biomed. Anal. 109, 128\u2013135 (2015).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"20266_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/bs.mie.2019.06.001","volume":"629","author":"JS Lehmann","year":"2019","unstructured":"Lehmann, J. S. et al. Bead-assisted multiplex cytokine profiling by flow cytometry. Methods Enzymol. 629, 151\u2013176 (2019).","journal-title":"Methods Enzymol."},{"issue":"1","key":"20266_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12882-020-01805-w","volume":"21","author":"J Stanford","year":"2020","unstructured":"Stanford, J., Charlton, K., Stefoska-Needham, A., Ibrahim, R. & Lambert, K. The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature. BMC Nephrol. 21 (1), 215 (2020).","journal-title":"BMC Nephrol."},{"issue":"8","key":"20266_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann, E. R., Lam, Y. K. & Uhlig, H. H. Short-chain fatty acids: linking diet, the Microbiome and immunity. Nat. Rev. Immunol. 24 (8), 577\u2013595 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"20266_CR27","doi-asserted-by":"crossref","unstructured":"Corte-Iglesias, V. et al. Propionate and butyrate counteract renal damage and progression to chronic kidney disease. Nephrol Dial Transplant. 40(1), 133\u2013150 (2024).","DOI":"10.1093\/ndt\/gfae118"},{"issue":"4","key":"20266_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/10408398.2020.1740645","volume":"61","author":"HJ Zheng","year":"2021","unstructured":"Zheng, H. J. et al. Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials. Crit. Rev. Food Sci. Nutr. 61 (4), 577\u2013598 (2021).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"4","key":"20266_CR29","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/advances\/nmab010","volume":"12","author":"Y Zeng","year":"2021","unstructured":"Zeng, Y. et al. Gut Microbiota-Derived trimethylamine N-Oxide and kidney function: A systematic review and Meta-Analysis. Adv. Nutr. 12 (4), 1286\u20131304 (2021).","journal-title":"Adv. Nutr."},{"issue":"9","key":"20266_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","volume":"15","author":"B Meijers","year":"2019","unstructured":"Meijers, B., Evenepoel, P. & Anders, H. J. Intestinal Microbiome and fitness in kidney disease. Nat. Rev. Nephrol. 15 (9), 531\u2013545 (2019).","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"20266_CR31","doi-asserted-by":"publisher","first-page":"e0141738","DOI":"10.1371\/journal.pone.0141738","volume":"11","author":"C Missailidis","year":"2016","unstructured":"Missailidis, C. et al. Serum Trimethylamine-N-Oxide is strongly related to renal function and predicts outcome in chronic kidney disease. PLoS One. 11 (1), e0141738 (2016).","journal-title":"PLoS One"},{"key":"20266_CR32","doi-asserted-by":"crossref","unstructured":"Constantino-Jonapa, L. A. et al. Contribution of trimethylamine N-Oxide (TMAO) to chronic inflammatory and degenerative diseases. Biomedicines.  11(2), 431 (2023).","DOI":"10.3390\/biomedicines11020431"},{"key":"20266_CR33","doi-asserted-by":"publisher","first-page":"682482","DOI":"10.3389\/fphys.2021.682482","volume":"12","author":"Q Fang","year":"2021","unstructured":"Fang, Q. et al. Trimethylamine N-Oxide exacerbates renal inflammation and fibrosis in rats with diabetic kidney disease. Front. Physiol. 12, 682482 (2021).","journal-title":"Front. Physiol."},{"issue":"25","key":"20266_CR34","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1080\/10408398.2022.2045894","volume":"63","author":"S Ghaffari","year":"2023","unstructured":"Ghaffari, S. et al. Akkermansia muciniphila: from its critical role in human health to strategies for promoting its abundance in human gut Microbiome. Crit. Rev. Food Sci. Nutr. 63 (25), 7357\u20137377 (2023).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"6","key":"20266_CR35","doi-asserted-by":"publisher","first-page":"e99915","DOI":"10.1371\/journal.pone.0099915","volume":"9","author":"H Kittaka","year":"2014","unstructured":"Kittaka, H. et al. Usefulness of intestinal fatty acid-binding protein in predicting strangulated small bowel obstruction. PLoS One. 9 (6), e99915 (2014).","journal-title":"PLoS One"},{"key":"20266_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12986-016-0089-7","volume":"13","author":"E Lau","year":"2016","unstructured":"Lau, E. et al. The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity. Nutr. Metab. (Lond). 13, 31 (2016).","journal-title":"Nutr. Metab. (Lond)"},{"key":"20266_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jss.2018.04.057","volume":"230","author":"K Okada","year":"2018","unstructured":"Okada, K. et al. Intestinal fatty acid-binding protein levels in patients with chronic renal failure. J. Surg. Res. 230, 94\u2013100 (2018).","journal-title":"J. Surg. Res."},{"issue":"12","key":"20266_CR38","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41579-019-0256-8","volume":"17","author":"AA Kolodziejczyk","year":"2019","unstructured":"Kolodziejczyk, A. A., Zheng, D. & Elinav, E. Diet-microbiota interactions and personalized nutrition. Nat. Rev. Microbiol. 17 (12), 742\u2013753 (2019).","journal-title":"Nat. Rev. Microbiol."},{"issue":"8-9","key":"20266_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1159\/000526957","volume":"53","author":"M Serrano","year":"2022","unstructured":"Serrano, M. et al. Dietary protein and fiber affect gut Microbiome and Treg\/Th17 commitment in chronic kidney disease mice. Am. J. Nephrol. 53 (8-9), 646\u2013651 (2022).","journal-title":"Am. J. Nephrol."},{"key":"20266_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fcimb.2019.00206","volume":"9","author":"F Li","year":"2019","unstructured":"Li, F., Wang, M., Wang, J., Li, R. & Zhang, Y. Alterations to the gut microbiota and their correlation with inflammatory factors in chronic kidney disease. Front. Cell. Infect. Microbiol. 9, 206 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"20266_CR41","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41598-023-27919-3","volume":"13","author":"N Tian","year":"2023","unstructured":"Tian, N. et al. Relationship between gut microbiota and nutritional status in patients on peritoneal Dialysis. Sci. Rep. 13 (1), 1572 (2023).","journal-title":"Sci. Rep."},{"issue":"2","key":"20266_CR42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","volume":"83","author":"ND Vaziri","year":"2013","unstructured":"Vaziri, N. D. et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83 (2), 308\u2013315 (2013).","journal-title":"Kidney Int."},{"issue":"10","key":"20266_CR43","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1093\/ndt\/gfaa087","volume":"36","author":"WL Lau","year":"2021","unstructured":"Lau, W. L., Chang, Y. & Vaziri, N. D. The consequences of altered microbiota in immune-related chronic kidney disease. Nephrol. Dial Transpl. 36 (10), 1791\u20131798 (2021).","journal-title":"Nephrol. Dial Transpl."},{"key":"20266_CR44","doi-asserted-by":"crossref","unstructured":"Gurung, M. et al. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine ; 51: 102590. (2020).","DOI":"10.1016\/j.ebiom.2019.11.051"},{"key":"20266_CR45","doi-asserted-by":"publisher","first-page":"1313651","DOI":"10.3389\/fendo.2024.1313651","volume":"15","author":"S Song","year":"2024","unstructured":"Song, S., Zhang, Q., Zhang, L., Zhou, X. & Yu, J. A two-sample bidirectional Mendelian randomization analysis investigates associations between gut microbiota and type 2 diabetes mellitus. Front. Endocrinol. (Lausanne). 15, 1313651 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"20266_CR46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang, W. H. et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116 (3), 448\u2013455 (2015).","journal-title":"Circ. Res."},{"issue":"1","key":"20266_CR47","doi-asserted-by":"publisher","first-page":"2215542","DOI":"10.1080\/07853890.2023.2215542","volume":"55","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis. Ann. Med. 55 (1), 2215542 (2023).","journal-title":"Ann. Med."},{"issue":"1","key":"20266_CR48","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41598-020-80063-0","volume":"11","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice. Sci. Rep. 11 (1), 518 (2021).","journal-title":"Sci. Rep."},{"issue":"10","key":"20266_CR49","first-page":"CD013631","volume":"10","author":"TE Cooper","year":"2023","unstructured":"Cooper, T. E. et al. Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cochrane Database Syst. Rev. 10 (10), CD013631 (2023).","journal-title":"Cochrane Database Syst. Rev."},{"key":"20266_CR50","doi-asserted-by":"publisher","first-page":"1303076","DOI":"10.3389\/fimmu.2023.1303076","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Role of MCP-1 as an inflammatory biomarker in nephropathy. Front. Immunol. 14, 1303076 (2023).","journal-title":"Front. Immunol."},{"issue":"6","key":"20266_CR51","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.kint.2022.09.004","volume":"102","author":"A Chen","year":"2022","unstructured":"Chen, A., Lee, K. & He, J. C. Treating crescentic glomerulonephritis by targeting macrophages. Kidney Int. 102 (6), 1212\u20131214 (2022).","journal-title":"Kidney Int."},{"issue":"1","key":"20266_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1681\/ASN.2020040487","volume":"32","author":"SJ Schrauben","year":"2021","unstructured":"Schrauben, S. J. et al. Association of multiple plasma biomarker concentrations with progression of prevalent diabetic kidney disease: findings from the chronic renal insufficiency cohort (CRIC) study. J. Am. Soc. Nephrol. 32 (1), 115\u2013126 (2021).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"20266_CR53","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/s41419-022-05394-4","volume":"13","author":"J Luan","year":"2022","unstructured":"Luan, J. et al. IL-18 deficiency ameliorates the progression from AKI to CKD. Cell. Death Dis. 13 (11), 957 (2022).","journal-title":"Cell. Death Dis."},{"issue":"11","key":"20266_CR54","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.metabol.2009.04.031","volume":"58","author":"M Troseid","year":"2009","unstructured":"Troseid, M., Arnesen, H., Hjerkinn, E. M. & Seljeflot, I. Serum levels of interleukin-18 are reduced by diet and n-3 fatty acid intervention in elderly high-risk men. Metabolism 58 (11), 1543\u20131549 (2009).","journal-title":"Metabolism"},{"key":"20266_CR55","doi-asserted-by":"crossref","unstructured":"Lai, S. et al. Effect of Low-Protein diet and inulin on microbiota and clinical parameters in patients with chronic kidney disease. Nutrients.  11(12), 3006 (2019).","DOI":"10.3390\/nu11123006"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20266-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20266-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:05:51Z","timestamp":1760612751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20266-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20266-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"3 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received approval from the Ethical Review Board of the Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand (IRB No. 0436\/66). It was conducted following international guidelines for human research protection, as outlined in the Declaration of Helsinki, The Belmont Report, the CIOMS Guideline, and the International Conference on Harmonization in Good Clinical Practice (ICH-GCP). Informed consent was obtained from all subjects and\/or their legal guardian(s).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical consideration"}}],"article-number":"36274"}}